Identification of new molecular markers for multiple myeloma paves path for more precise therapies

MedicalXpress | juil. 01, 2026

Researchers at Cima and Clinica Universidad de Navarra have identified new molecular mechanisms underlying multiple myeloma. This type of hematologic cancer, which affects the bone marrow, is characterized by its resistance to treatment, leading to relapses in patients. The researchers' paper is published in the journal Blood.